"Leaf Biotech" has completed its Series B2 financing round.

According to 36Kr and Livzon Bio's official WeChat account, Livzon Bio recently secured hundreds of millions of yuan in Series B2 financing. This round was led by Xinfengming Group, with participation from GGV Capital and existing shareholders Guoyuan Equity and Hefei Innovation Investment.